A Pilot Study of Edoxaban in Patients with Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

COVID-19 update:

In response to the COVID pandemic, Scripps Health has temporarily suspended enrollment for all clinical trials. Exceptions will exist for trials with curative intent, life-saving treatment or when no standard of care exists. For questions, please call Scripps Office for the Protection of Research Subjects at 858-678-6402.

Trial ID:
Matthew Price
This is a single arm, open label, single site study assessing the feasibility of post-procedural edoxaban therapy in atrial fibrillation (AF) patients after clinically indicated WATCHMAN left atrial appendage (LAA) closure.

Inclusion Criteria:

  • The patient has documented paroxysmal, persistent, or permanent non-valvular AF (i.e., the patient has not been diagnosed with rheumatic mitral valve disease).
  • LAA closure with the WATCHMAN device is planned
  • The patient fulfills the FDA indication for WATCHMAN LAA closure
  • The patient or legal representative is able to understand and willing to provide written informed consent to participate in the trial
  • The patient is able and willing to return for required follow-up visits and examinations.
  • The patient is 18 years of age or older

Exclusion Criteria:

  • Conditions other than atrial fibrillation that require anti-coagulation (e.g., a prosthetic heart valve)
  • Stroke within the previous 7 days
  • Hypersensitivity to edoxaban
  • Moderate or severe mitral stenosis
  • A need for aspirin at a dose of >81 mg a day
  • A need for on-going treatment with dual antiplatelet therapy with aspirin and clopidogrel
  • A need for on-going treatment with ticagrelor or prasugrel
  • No LAA closure device implanted during procedure
  • Procedural complication of LAA closure (e.g., stroke, systemic embolism, bleeding, vascular complication [e.g., groin hematoma >10cm, AV fistula, or pseudoaneurysm), or serious pericardial effusion)
  • Planned surgery or invasive procedure within 6±2 weeks of enrollment

Contact Info:

  • Catchpole Heather
  • Catchpole.Heather@scrippshealth.org
  • 858-824-4248

Why isn't this trial accepting new patients?

The trial may have a limited enrollment number, reached its maximum, or come to the end of its enrollment period. View trials that are recruiting

How else can Scripps help me?

We have a broad range of physician expertise and specialized medical services available. You can find a doctor online, call 1-800-SCRIPPS (1-800-727-4777) for personal help, or see related Scripps services.

How can I find trials that are accepting new participants?

For more information, see a list of trials that are recruiting, or call the clinical research office at 858-648-6402 for help.